Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan

Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan - Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036846

Enrollment

Registered

2019-05-27

Start date

2016-09-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosed as malignant tumor of lung. Diagnosed as interstitial lung disease. Case of radiotherapy.

Exclusion criteria

Exclusion criteria: Patients who have refused to use data.

Design outcomes

Primary

Measure	Time frame
The ratio of acute exacerbation	—

Secondary

Measure	Time frame
The ratio of acute exacerbation related death The ratio of interstitial lung disease on radiation therapy for lung cancer	—

Countries

Japan

Contacts

Public ContactYasuhito Hagiwara

Yamagata University Faculty of Medicine Department of Radiation Oncology

hagiwara.yasuhito@gmail.com023-628-5386

Outcome results